Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?

CONTEXT: Diabetes mellitus is a risk factor for nephrolithiasis. A recent observational study found that in patients with type 2 diabetes (T2D), SGLT2 inhibitor use was associated with a 49% lower risk of nephrolithiasis compared with GLP-1 receptor agonists. OBJECTIVE: We examined the association b...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramanian, Priyadarshini, Wanner, Christoph, Ferreira, João Pedro, Ofstad, Anne Pernille, Elsaesser, Amelie, Zinman, Bernard, Inzucchi, Silvio E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202688/
https://www.ncbi.nlm.nih.gov/pubmed/35290464
http://dx.doi.org/10.1210/clinem/dgac154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202688/
https://www.ncbi.nlm.nih.gov/pubmed/35290464
http://dx.doi.org/10.1210/clinem/dgac154

Ejemplares similares